AU2002231637A1 - Production and use of a targeted diagnostic system - Google Patents

Production and use of a targeted diagnostic system

Info

Publication number
AU2002231637A1
AU2002231637A1 AU2002231637A AU3163702A AU2002231637A1 AU 2002231637 A1 AU2002231637 A1 AU 2002231637A1 AU 2002231637 A AU2002231637 A AU 2002231637A AU 3163702 A AU3163702 A AU 3163702A AU 2002231637 A1 AU2002231637 A1 AU 2002231637A1
Authority
AU
Australia
Prior art keywords
production
diagnostic system
targeted diagnostic
targeted
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002231637A
Inventor
Sabine Brusselbach
Alfred Fahr
Andreas Graser
Rolf Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectron Therapeutics AG
Original Assignee
Vectron Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectron Therapeutics AG filed Critical Vectron Therapeutics AG
Publication of AU2002231637A1 publication Critical patent/AU2002231637A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
AU2002231637A 2000-11-22 2001-11-22 Production and use of a targeted diagnostic system Abandoned AU2002231637A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25266600P 2000-11-22 2000-11-22
US60/252,666 2000-11-22
PCT/EP2001/013618 WO2002041870A2 (en) 2000-11-22 2001-11-22 Production and use of a targeted diagnostic system

Publications (1)

Publication Number Publication Date
AU2002231637A1 true AU2002231637A1 (en) 2002-06-03

Family

ID=22956996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002231637A Abandoned AU2002231637A1 (en) 2000-11-22 2001-11-22 Production and use of a targeted diagnostic system

Country Status (3)

Country Link
EP (1) EP1209469A1 (en)
AU (1) AU2002231637A1 (en)
WO (1) WO2002041870A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1538164A1 (en) * 2003-12-04 2005-06-08 Vectron Therapeutics AG RGD targeting moiety its production and use
JP2006248978A (en) 2005-03-10 2006-09-21 Mebiopharm Co Ltd New liposome preparation
CN109996809A (en) 2016-11-14 2019-07-09 诺华股份有限公司 Composition relevant to fusogenic protein MINION, method and therapeutical uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US5512294A (en) * 1994-08-05 1996-04-30 Li; King C. Targeted polymerized liposome contrast agents
AU6691496A (en) * 1995-08-01 1997-02-26 Advanced Therapies, Inc. Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
WO1998008094A1 (en) * 1996-08-23 1998-02-26 Amcell Corporation Sensitive detection of cell surface markers on viable cells

Also Published As

Publication number Publication date
WO2002041870A3 (en) 2002-11-07
WO2002041870A2 (en) 2002-05-30
EP1209469A1 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
AU2001292836A1 (en) Endoscopic targeting method and system
AU2001275047A1 (en) Method of graphically indicating patient information
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2002239740A1 (en) Nanolithography methods and products therefor and produced thereby
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU715620C (en) Therapeutic methods and uses
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2001233208A1 (en) Human sulfatases
AU5886500A (en) Indolyl-benzimidazole antibacterials, and methods of use thereof
AU2002224553A1 (en) Human proteases
AU4367700A (en) Human kinesins and methods of producing and purifying human kinesins
AU2002222650A1 (en) Flexible die and method of manufacturing the flexible die
AU2001240731A1 (en) Monitoring system and its use
AU3553400A (en) Use and production of polypropylene
AU2001236234A1 (en) Patient monitoring devices and methods
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001258533A1 (en) Construction of dies
AU2002231637A1 (en) Production and use of a targeted diagnostic system
AU2001228624A1 (en) Implements and their manufacture
AU2001240411A1 (en) Production of an embossing tool and use of the same
AU2001249700A1 (en) 33167, a novel human hydrolase and uses therefor
AU2001241583A1 (en) A human pyridoxal-phosphate dependent enzyme family member and uses therefor
AU3865400A (en) Animal model of allergies